These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8722722)

  • 1. Organizational guidelines for therapeutic apheresis facilities. American Society for Apheresis Standards and Education Committee.
    J Clin Apher; 1996; 11(1):42-5. PubMed ID: 8722722
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of training and competency of apheresis specialists: organizational guidelines for therapeutic apheresis facilities.
    J Clin Apher; 1998; 13(4):174-89. PubMed ID: 9886797
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for therapeutic apheresis clinical privileges.
    American Society for Apheresis
    J Clin Apher; 2007 Jun; 22(3):181-2. PubMed ID: 17377977
    [No Abstract]   [Full Text] [Related]  

  • 4. Internet-based quality assurance registry for LDL apheresis QUASA--the apheresis registry.
    Dräger J; Petzold S; Ristau H; Trepte S
    Transfus Apher Sci; 2005 Oct; 33(2):81-5. PubMed ID: 16137926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
    Szczepiorkowski ZM; Winters JL; Bandarenko N; Kim HC; Linenberger ML; Marques MB; Sarode R; Schwartz J; Weinstein R; Shaz BH;
    J Clin Apher; 2010; 25(3):83-177. PubMed ID: 20568098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How we developed and use the American Society for Apheresis guidelines for therapeutic apheresis procedures.
    Shaz BH; Schwartz J; Winters JL
    Transfusion; 2014 Jan; 54(1):17-25. PubMed ID: 24261606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
    Szczepiorkowski ZM; Bandarenko N; Kim HC; Linenberger ML; Marques MB; Sarode R; Schwartz J; Shaz BH; Weinstein R; Wirk A; Winters JL; ;
    J Clin Apher; 2007 Jun; 22(3):106-75. PubMed ID: 17394188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Category IV indications for therapeutic apheresis: ASFA fourth special issue.
    Shaz BH; Linenberger ML; Bandarenko N; Winters JL; Kim HC; Marques MB; Sarode R; Schwartz J; Weinstein R; Wirk A; Szczepiorkowski ZM
    J Clin Apher; 2007 Jun; 22(3):176-80. PubMed ID: 17377982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exclusive therapeutic apheresis delivery system.
    Kiprov DD; Rohe R; Hofmann J
    Transfus Apher Sci; 2003 Apr; 28(2):173-9. PubMed ID: 12679123
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines for documentation of therapeutic apheresis procedures in the medical record by apheresis physicians.
    American Society for Apheresis
    J Clin Apher; 2007 Jun; 22(3):183. PubMed ID: 17377976
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.
    Schwartz J; Winters JL; Padmanabhan A; Balogun RA; Delaney M; Linenberger ML; Szczepiorkowski ZM; Williams ME; Wu Y; Shaz BH
    J Clin Apher; 2013 Jul; 28(3):145-284. PubMed ID: 23868759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic apheresis: treatment in search of a disease.
    J Health Care Technol; 1985; 1(4):279-98. PubMed ID: 10274623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality standards in provision of facility based HIV care and treatment: a case study from Dar es Salaam Region, Tanzania.
    Mapunjo S; Urassa DP
    East Afr J Public Health; 2007 Apr; 4(1):12-8. PubMed ID: 17907755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic apheresis services provided by a community blood bank.
    Smith JW
    Transfus Apher Sci; 2003 Apr; 28(2):181-5. PubMed ID: 12679124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nephrology based mobile extracorporeal therapy service.
    Sweet R; Golden PJ
    Transfus Apher Sci; 2003 Apr; 28(2):187-95. PubMed ID: 12679125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis.
    Winters JL
    J Clin Apher; 2011; 26(5):239-42. PubMed ID: 21882234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Canadian apheresis registry.
    Rock G; Clark B; Sutton D; ;
    Transfus Apher Sci; 2003 Oct; 29(2):167-77. PubMed ID: 12941357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical updates in the 7
    Ipe TS; Pham HP; Williams LA
    J Clin Apher; 2018 Feb; 33(1):78-94. PubMed ID: 28653762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.
    Howell C; Douglas K; Cho G; El-Ghariani K; Taylor P; Potok D; Rintala T; Watkins S
    Transfus Med; 2015 Apr; 25(2):57-78. PubMed ID: 26013470
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for apheresis personnel--an overview.
    Cole B
    J Clin Apher; 1985; 2(4):311-4. PubMed ID: 4066632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.